Skip to main content

Balancing Grafts and Glucose: SGLT-2 Inhibitors and GLP-1 Agonists in Transplant Recipients


Date: Feb 10, 2025 01:00 PM - 02:00 PM

Fee

$0.00

CE Hours

1.00

CE Units

0.100

Registration closes on Apr 12, 2025 01:00 AM

Activity Type

Application

Target Audience(s)

Pharmacists

Accreditation(s)

Accreditation Council for Pharmacy Education
Medical University of South Carolina is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

Requirements for CE Credit

To receive CE credit, the post-evaluation must be completed within 60 days of the presentation.

 

Balancing Grafts and Glucose: SGLT-2 Inhibitors and GLP-1 Agonists in Transplant Recipients
Registration Closed  

Objectives

  • Discuss the prevalence and unique challenges for the impact of diabetes in solid organ transplant recipients
  • Review clinical studies demonstrating the efficacy and safety of sodium glucose co-transporter 2 (SGLT-2) inhibitors and glucagon-like peptide-1 receptor agonists (GLP-1) in transplant patients
  • Outline practical strategies for initiating and monitoring SGLT-2 inhibitors and GLP-1 receptor agonists in solid organ transplant recipients

Speaker(s)/Author(s)

Drea Cangelose, PharmD
PGY-2 Solid Organ Transplant Resident

Activity Number

0682-0000-25-006-L01-P
Date: 02/10/25
Time: 01:00 PM - 02:00 PM

CE Hours

1.00

Location

Storm Eye Auditorium HA809
Registration Closed